Results 241 to 250 of about 644,115 (313)

Betrixaban: An Oral Factor Xa Inhibitor [PDF]

Clinical Research and Trials, 2017
openaire   +1 more source

Factor Xa inhibitors versus low-molecular-weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Amin L, Qayyum K, Uzair M, Khan F, Sethi P, Hanif L, Azhar A, Mazhar S, Ejaz U, Jawad S.   +9 more
europepmc   +1 more source

Lysis of thrombus located in the left atrial appendage. Is it the right time for a Xa factor inhibitor?

, 2013
Jakub Baran, Beata Zaborska, Małgorzata Sikora-Frąc, Sebastian Stec, Piotr Kułakowski   +4 more
openalex   +2 more sources

Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation

Cochrane Database of Systematic Reviews, 2013
K. B. Slot, E. Berge
semanticscholar   +1 more source

Two Acidic, Anticoagulant PLA2 Isoenzymes Purified from the Venom of Monocled Cobra Naja kaouthia Exhibit Different Potency to Inhibit Thrombin and Factor Xa via Phospholipids Independent, Non-Enzymatic Mechanism

, 2014
Ashis K. Mukherjee, Bhargab Kalita, Rupamoni Thakur   +2 more
openalex   +2 more sources

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. [PDF]

Clin Pharmacokinet
Rohr BS, Krohmer E, Foerster KI, Burhenne J, Schulz M, Blank A, Mikus G, Haefeli WE.   +7 more
europepmc   +1 more source

Role of Oral Factor Xa Inhibitors after Acute Coronary Syndrome

The Cardiology, 2014
Abhishek Sharma, Akash Garg, J. Borer, P. Krishnamoorthy, Jalaj Garg, C. Lavie, A. Arbab-Zadeh, D. Mukherjee, H. Ahmad, E. Lichstein   +9 more
semanticscholar   +1 more source

Factor Xa inhibitors versus warfarin in patients with non-valvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Zahoor MM, Mazhar S, Azhar A, Mand Khan F, Anees U, Vohra RR, Ejaz U, Jawad S.   +7 more
europepmc   +1 more source

Features of application of Factor Xa inhibitor at patients with damages of large segments of the lower extremities

, 2015
A. A. Fayzullin, Т. Б. Минасов, O S Usatova, L I Mukhamedyanova, И. Р. Гафаров   +4 more
openalex   +1 more source

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. [PDF]

Eur Stroke J
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C.   +14 more
europepmc   +1 more source